Fisher & Paykel Healthcare addresses minor breach involving two accounts
- Fisher & Paykel Healthcare detected unlawful access to two employee email accounts and a subset of company files.
- The company's ASX-listed shares dipped 0.3% to $39.74 following the market announcement.
- Management confirmed operations, manufacturing, supply chains, and financial targets remain fully unaffected.
Fisher & Paykel Healthcare (ASX:FPH) announced it detected unauthorised and unlawful access to two employee email accounts along with a subset of corporate files.
The security event stands in stark contrast to broader cyber disruptions, as no patient databases, core manufacturing systems, or supply chain logistics suffered interference.
"There has been no impact to the company's products, manufacturing operations or supply chain, and its ability to supply and support customers and patients continues uninterrupted," stated Fisher & Paykel Healthcare in an official market disclosure.
The group noted that some accessed files contained personally identifiable information and confirmed it is currently notifying affected individuals alongside relevant authorities.
The medical device manufacturer confirmed it found no evidence of ransomware or malware and expects no material impact on its overall operations or financial performance.
Following the announcement, the Fisher & Paykel Healthcare share price was down at $39.74.
The Auckland-headquartered company designs, manufactures, and markets medical products for acute and chronic respiratory care, surgery, and obstructive sleep apnea treatments globally.
With sales spanning over 120 countries, the firm relies on stringent response protocols to maintain operational continuity across its international business network.
